壹、審查依據及一般原則－ 生效( 更新)

Transcription

1 1

2 4 4 4 (Tw-DRGs) ( ) 22 ( ) 30 ( ) 51 ( ) 65 ( ) 69 ( ) 87 ( ) 82 ( ) 86 ( ) 90 ( ) 99 () 104 () 109 () 113 () 118 () 121 () 123 () 124 Tw-DRG DRG MDC2 130 MDC5 131 MDC6 133 MDC8 137 MDC MDC

3 MDC

4 * (100/11/1)() (100/11/1) ( ) 1. (100/11/1) ( 4

5 ) (100/11/1) ( ) 1. (100/11/1) ( ) 1. (100/11/1) 2. (100/11/1) ( ) 1. (100/11/1) 2. (100/11/1) 3. (1) ( 5

6 ) (100/11/1) (100/11/1) (2) (100/11/1) (3) (100/11/1) (4) (100/11/1) 4. (100/11/1) 5. (100/11/1) 6

7 (100/11/1)() 1. (1) (2) (3) 2. (1) (2) 3. (1) (2) 4. (1) a b OD OD c O.D d O.D e O.D f O.D. g O.D. h O.D. a. 5% b. 1% (2) 5.(1) 1% (2) 7

8 (100/11/1)() * (Tw-DRGs) ( )(99/7/1) ( )

9 (99/7/1) ( ) ( ) ( )

10 (99/7/1) ( ) ( ) ( ) ( ) 1 cephalothin, cefazolin, cephradine, cephaloridine, cephapirin 2 cephamycin cefamandole, cefonicid, cefuroxime, cefotiam 10

11 3 Cephamycin cefoxitin, cefmetazole 4 Pseudomonas cefotaxime, ceftizoxime, ceftriazone, cefmenoxime 5 Aminoglycoside tobramycin netilmicin 6 Fluoroquinolone norfloxacin, ofloxacin, enoxacin, ciprofloxacin 7 Glycopeptide vancomycin teicoplanin 8 β-lactamase inhibitor Augmentin Unasyn ( ) ( ) 1.( ) (99/7/1) 2. () 1. 20% C 11

12 13016B () () (1)( ( ) (2) 12

13 (3) (4) (97/5/1) (100/11/1) () () () () () 1. (1) A. 13

14 B. C. D. ()( ) E. (2) A. B. C. D. ()( ) E. (procedure of choice) 14

15 (procedure of choice) (99/7/1) () (95/7/15) () (98/3/1) ( ) (95/7/15) 1. ( 1. 2.malignant ) arrhythmia

16

17 (1) (2) (3) (4) (5) 3. (1) (2) (3) (4) (5) 17

18

19 ( ) (DNR) DNR (97/5/1) ( ) ( ID ) (97/5/1) ( ) (99/1/1) (100/11/1)() ( ) ( )83079BRadiofrequency coagulation(rf) 19

20 1. (1) Image-guided OP note (2) 3 (3) (image-guided diagnostic block) 2 RF 2. (1) (Facet Joint Syndrome) (2) (3) Neuropathic painpostherpetic neuropathic pain (4) Failed Back Surgery Syndrome,FBSS(Chronic spinal pain) 3. (1) (2) 20

21 (99/7/1)(100/5/1) 21

22 ( ) 1. (1). (2). 97/6/ Penicillins & 10.3 Cephalosporins (100/1/1) (2) (100/1/1) (3) (100/1/1) (3). (4). 22

23 48004C 48006C 48022C 48024C 48033C 48035C Balance Salt Solution Physiologic Irrigating Solution 23

24 64141C 64274C64275C A. ( ) 69014B 69015B ( ) 69019B (C) ( ) ( ) 69019B B 1/2 B B 69015B C B 69017B 2. (1). IV Push 57111C (2). 24

25 (3) B (4). (5). (6). (7). (8). (97/5/1) (9). (10). (11). tocolytics β-mimetics (12). (13). 25

26 (vial) (ampoule) 14. (54019C 54027C 54037C 54038C) (99/7/1) 3. () (1). (2). ( ) (3). (4). (5). (6). (7). 26

27 (8). IV Push 4. (1) (1) (100/1/1) X (100/1/1) (3) (100/1/1) (2) (3) 7. (1) ( ) (2) 27

28 A. KARNOFSKY SCALE() ( ) ()60 ( ) B. C. D. (A) (B) (C) A. B. (3) A. B. ( ) ( ) C. 28

29 D. E. A. B. 1. ( ) ( ) (99/7/1) 29

30 ( ) 1. (1) (2) (3) (4) (5) (6) MRI CT (7) (8) ( ) (9) sulfonylureas (glimepiride ) meglitinides ( repaglinide nateglinide) (10) ACEI ARB 30

31 potassium-sparing diuretics aldosterone antagonist -blocker pacemaker-blocker (5) thiazide diuretics (99/7/1) (6) ACEI (99/7/1) thiazide diuretics (11)serotonin antagonist (12)TZD thiazolidinedione (IGT) 3 6 HbA1c metformin metformin TZD (97/5/1) (13) 90 (97/5/1) 31

32 (14)(47020C) (97/5/1) 2. (1) (2) IV Push (3) (4) (5) (6)GOT GPT HBSAG Anti HCV Anti HBS ( B ) (99/7/1) (7) CCr 10 ml/min UF<2.0 CCr (97/5/1) Ccr 24 Cr measured Ccrestimated Ccr CG-GFR Cockcroft-Gault =140-Age Bwt / 72 Cr 1.73/ BSA 0.85 if female 32

33 MDRD-Simplify-GFR=186 Scr Age if female (97/5/1) ( ) A. Cr 6.0 CCr 5ml/min Ccr 24 CG MDRD (97/5/1) B. UF< C. A. B. BMI data C. residual renal function CCR D. Albumin E. (8)BC ALT ( bilirubin >2mg/dL, PT prolong>3 sec) BC HBV DNA HCV RNA B 6 12 HBV DNA C ( RVR) 6 HCV RNA 6 (99/7/1) 33

34 3. () (1) (2) ( ) (3) (4) (5) (6) (7) (8) IV Push 4. 34

35 5. (1)EPO ( ) (2) Kt/V Kt/V /1.73 (100/5/1) (3)(98/3/1) 09041B 17002B Pimax and Pemax ( ) Try weaning (97/5/1) 35

36 17007B 1. (flow volume curve) flow volume curve B 17003B 17004B B Try weaning (97/5/1) 47045C C (1) (2) (3) 2. x (99/7/1) (99/7/1) 56022C C 57009B ( ) 1. manual resuscitation-bag B ( ) 1. (57011B) 36

37 57015B 57016B 57017B 57018B ( ) ( ) ( ) ( ) (1) (2) 2. (57010B) (1) COPD (2) (3) 3. (57012B) (1) (2) (3)

38 57021C 57022C 57024B ( ) ( ) ( ) 1. COPD,bronchiectasis, asthma,pneumonia ( ) B B 57021C 57022C (99/7/1) 1. MDI COPD,bronchiectasis,asthma,pneumon ia ( ) (99/7/1) B 57021C 57022C (99/7/1) (4) 47032B 47033B 57017B 57018B (5) (97/5/1) (6) () 38

39 (7) 8. ( 33076B-33078B) ( 18020B-18022B) ( 18020B-18021B) 18022B(99/7/1) (9) (97/5/1)(99/7/1) (10) (11) 18005B() 18006B( ) 18007B( ) 18007B 18006B (3)18007B (99/7/1) (12) 26025B 39

40 (26024B) (26025B) A. B. C. D. - E. F. G. H. I. J. K. L. (26024B) A B 40

41 A. B. (13) (single lumen) 47015B( ) (double lumen) 69006C( ) (14) UGI series (15) 17003C 17006B 17007B 17019C 17003C 17006B 17007B, 17006B 17019C (97/5/1) (16) 18024B 18025B (17) (97/5/1) 41

42 (18) EPO ( ) (19)(CAVH) 58007C (1) (2) (3) severe volume overloading (20) (21-1) (96/4/1) (21-2) (96/4/1) (21-3) C (96/4/1) (21-4) B C C (96/4/1) (22) 1 (97/5/1) (23) Port-A 48010C 42

43 (24) (WBC 1,500 50,000) 08011C (25) ( 3000cc ) 93008C 94201B94202B 94001C (26) A. B. C. D. A. () B. (27) 97/9/1 A. - B. - 97/9/1 43

44 A. -- B. -- C. --SMA D. -- E. F. (A) ( ) (B) -- A. - ( ) B. - ( ) C. - D. - A. -( ) B. - C. - 44

45 D. A. - B. - C. - D. IV pump RCW /9/1 (28) (96/4/1) 1 1 ( ) (99/7/1)(100/1/1) 45

46 (29) (96/4/1) A. (/ (69006C) (47059B 47061B)): CCr 15 ml/min (Cr) 6.0 mg/dl A., B.,C.,D.,E.,F.,G.,H. (cachexia),i. (BUN > 100 mg/dl) B. (A) 69032C (B)69034C (C) 47059B 47061B 46

47 C. (A) a. CCr 15 ml/min b. (Cr) 6 mg/dl c. (B) (AV graft) a. CCr 12.5 ml/min b. (Cr) 7 mg/dl c. (C) (AV graft) a. CCr 10 ml/min b. (Cr) 8 mg/dl c. (D) 30 (Cr) 6 mg/dl 4 (Cr) 5 mg/dl D. A B 47

48 B. (A) CCr 15 ml/min (B) (Cr) 6 mg/dl (C) C. (A) CCr 10 ml/min (B) (Cr) 8 mg/dl (C) D. 30 (Cr) 6 mg/dl 4 (Cr) 5 mg/dl (30) (97/5/1) (31) 17008B 57018B (97/5/1) (32), (56010B) (97/5/1) (33) (97/5/1) Total recording time 6 MSLT total recording time total sleep time sleep efficiency sleep onset latency REM latency sleep 48

49 stages histogram apnea-hypopnea index AHI respiratory disturbance index RDIperiodic leg movement index arousal index CPAP PSG AHI RDI 15/H 5 RDI 15/H Titration Chart (34) (97/5/1) CBC (35)(FFP) (97/5/1) 49

50

51 ( ) (1) (2) (3) 48014C 48017B 48018C 48021B (98/3/1) (4) 48014C 48021B (98/3/1) (5) 48014C 48018C 48013C 48018C (6) (7) (8) 48004C~48006C 51

52 48022C-48024C 48033C-48035C balance salt solution physiologic irrigating solution 7. (62032B 62036B) 8.( ) ( ) (Split thickness skin graft) B 72046B 72047B location

53 ( 1. ( N1 N2 ) (N1 N2 nodes) ) 13. (1) B 69015B B B B 1/2-- (2) 69014B 69015B (3) 69016B 69017B C ) (99/7/1)

54 17. (1) (2) 18. (1) C 62009C (2) 64087C( ) 19.(clean wound) (open drainage) (infected wound) ()(49004C) 49004C 48013C

55 C (1) (2)Danzen Varidase B 73012B 73012B 29. (1) (68025B) 68025B (2) (51020C) 32. (64116C) 55

56 (62010C) 33. (48001C) (56006C) 34. (64140C) (1) (2) (3) periappendicitis,fecalith,congestion 37.IV PUMP SET (1) heparin,dopamine levophed IV PUMP (2) intake output TPN IV PUMP (3) (1) 56

57 (2) (18008B) (1)(PAOD) (2) (IABP) (3)(ECMO) (4) (5) 42.RH(D) (11003C) 57

58 (1)Rh0(D) (2) 43.(75401B)(19006B) (19007B) (1)(75401B).....( ) (2) (19006B) (3)(19007B) 44.(29017C)(33026B) (1)(29017C) (2) (33026B) X 58

59 (78607C 4550 ) 46. tendon repair 47.(64208C) (gastric partition)72035b (1)BMI(body mass index) 40kg m2 BMI 35kg m2 ) (2).. 18~

60 49. (95/7/15) (1) 10 2 A. (A)B (B)C (C) (D) (E) (F) B. (A) Alagille Byler (B)PFIC progressive familial intrahepatic cholestasis (C) (D) (E) a. cystic fibrosis 60

61 b. nonsyndromic paucity of intrahepatic bile duct C. (A)Wilson (B) (C)Tyrosinemia D. (A) urea cycle defect (B)amyloidosis (C) E. (A) hepatocellular carcinoma (B)hepatoblastoma (C)hemangioendothelioma (D) (E) F. G. H. AASLD (A)Budd-Chiari syndrome (B)metastatic neuroendocrine tumor (C)polycystic disease (D) I

62 A. (A) total bilirubin>3mg/dl (B) total bilirubin>10mg/dl B. 3 C. 2 D. Grade2 2 E. F. INR>1.5 G. H. BW<3 percentile I. Child B (A) Milan criteria (B) UCSF criteria J. (diffuse-type hepatoma) K. L. M. 62

63 50.FTSG ( ) 2/3 (STSG) FTSG 80(97/5/1) C 48018C %TBSA(Total body surface area) (97/5/1) 52.(74417C) : (97/5/1) (1) (2) (3) (4),,, 53. (97/5/1) 54. (47059B) Port-A (47080B), (69005B) 15( ) (97/5/1)(99/7/1) B (99/7/1) C 1 63

64 62002C 1~2 ( ) (99/7/1) 64

65 ( ) 1. (1) (2) (3) 10.2 Penicillins & 10.3 Cephalosporins (100/1/1) (4) (97/5/1) (5)( ) (6) (7)(97/6/1) 65

66 (100/1/1) (100/1/1) A B C ( ) (8) (9) (48011C) (10)() (11) 14 (100/1/1) (12) Nebulizer (100/1/1) 66

67 (13) O2 tent O2 hood (57014B) (14) (30022C) IgE 2. (1) (2)( ) 3. (1) (2) 4. (1) ( ) (2) 67

68 (3) (4) (57009B) AMBU bag 57009B IMV Resuitator( ) IMV 57009B( ) (5) postural drainage(47045c) (97/5/1) 68

69 ( ) 1. (1) (2) (3) (4) (5) 55010C 2. (1) (2) (3) (4) 69

70 (5) 96004C 6. (99/7/1) 3. (1) (2) (3) (97/5/1) (4) (5) (6) (tocolytics) ()( ) (7)Clomiphene citrate 4.(80403B)(80412B) 70

71 (80413B) (1)80403B (2)80412B (parametrium) (3)(80413B) (80414B) 70208B 5. (1) (2)

72 8. ( ) 9. (1)13006C (2)16007C (80403B) (80404B) 3. (99/7/1) 11. (1)Fetal distress( ) (2)Failure to progress in active labor() (3)APH(placenta previa, equel te placenta)() 72

73 (4)Malpresentation(including twin with malpresentation)( ) (5)Cord equel te() (6)Induction failure( ) (7)Active genital herpes() (8)Previous C/S( ) (9)Previous uterine surgery() (10)Vulvar and/or vaginal condyloma equel te,diffuse( ) (11)Treatable fetal anomalies(e.g. gastroschisis,omphalocele,hydrocephaly)( ) (12)Preeclampsia with() uncorrectable severe preeclampsia HELLP syndrome with failed induction(6hrs) eclampsia with poor induction progress(6hrs) (13)Extremly premature fetus < 1500gm( NICU ) (<1500 ) (14)Pelvic deformity(equel of poliomyelitis or traffic accident,etc.)() (15)Fetal macrosomia(>4000gm EBW)(>4000 ) 73

74 (16)Cephalopelvic disproportion (CPD)( ) (17)Obsructive labor(e.g. myoma,ovarian tumor) ( ) (18)Major medical complications( ) (19) HIV(+)(98/8/1) (20) (98/8/1) 13. MTX 14. (101/2/1) () 15. (101/2/1) () 16. (28014C) 17. (18013C 18014C) 18035B

75 (1) (D&C) (2) (D&C) (3) (4) 21. urine acetone 22.Folliculometry Ketoconazole Mycostatin 25. IUD IUD displacement 26. PAP smear () 27.C/S (ATH, VTH ) 75

76 (1)C/S (ATH, VTH ) (2)(ATH, VTH ) 28. (97/5/1) 29. (1) (2) 30. (1) (D&C) (2) (D&C) (3) (4) (101/2/1) () Pulse or ear Oximetry(57017B) 76

77 (47031C) 35. conization 77

78 ( ) ( ) Gardnerbipolar prothesis Karnofsky Scale X-ray (100/1/1) % 3. 50% (cross link) ( )( ) 3 ( )( ) cross link( ) cross link 5. ( )(THR TKR) (custom-made) 78

79 (99/7/1) 7. k pin (97/5/1) 10.()( ) multiple fracture(2 components ) 2.open fracture 3.pediatric fracture 4.complications neuro vascular injury visceral organ injury infections etc 5.joint fracture or joint dislocation (101/2/1) 6.special condition femoral neck fracture 12. CRP ESR

80 (1)59007B (97/5/1) (Mader-Cierny II B ) (2)() (3) A B ( 33054B-33058B) 17.,,, 80

81 64243B( ) 64244B( ) 28001C( ) (97/5/1) 18. (101/2/1) 19. (101/2/1) 81

82 ( ) 1.(79404B 79405B 79406B 79411B 79412B 97401K 97402A 97403B) (1) (97/5/1) (2) BPH (3) (4) 78026C (5) C (97/5/1) 2. (1) (2) (79407C) 3. (1) ( ) U.V.J. stone ( )(78026C) ( ) U.V.J.stone 82

83 (99/7/1) (2) (3) (ESWL)(50023B 50024B 97405K 97406A 97420B 97407K 97408A 97421B 97409K 97410A 97422B 97411K 97412A 97423B) A B 1.KUB Sono 2.IVU 3.RP ESWL ESWL 0.5cm( 0.5cm ) () 4. PGE1 20mcg ( )Gn-RH Analogue staget3 N1 M1, PSA CT Scan MRI Bone Scan 83

84 (97/5/1)(99/7/1) 6. Video-urodynamic study (21006B) (21004C)(21007C)(21003C) 7.(50019C) 8. (05221A) (50011C) (37005B) 05221A 9. (50020C)(97/5/1) (1) (paraphimosis) (2) (3) (4) (5) 10.BPH bethanechol (97/5/1) (1)BPH bethanechol finasteride -blocker 3 (2) on Foley 84

85 detrusor (3) DM 1 (4)DM AUR (5)NB neurogenic bladder urinary retention on Foley 11.ESWL URS, (97/5/1) 12.,. (97/5/1) 13. -J,(97/5/1) 85

86 ( ) (54023C) 3.(57007C) (57021C) 4. (56019B )(56019B ) 5. ( ) 6. parotidectomy (71015B) (71019B) (71020B) (83030B)

87 (54019C)- (54027C) (54037C) (54038C) (97/5/1)(99/7/1)(100/1/1) 9. (65035B) 10. SMT UPPV (101/2/1) () 11. (1)(65072B) 90 (97/5/1) (2) (65074C) (3)()(65003C) (4) 12.(22008B) (22001B) 87

88 13. (1)28002C nasopharyngoscopy) (28003C sinoscopy) (28004C laryngoscopy) 1 FESS( )sinuscope (97/5/1) (100/1/1) ( ) (99/7/1) (2) stroboscopy. (28005B) (3) Laryngoscopy (28004C) Stroboscopy(28005B) (4) rigid ventilation bronchosocpy (67012C) (5) 88

89 (99/7/1) (6) (99/7/1) (1)(VFT) Nann Romberg VFT (2) (3) 16.() ()(97706K 97707A 97708B)( ) (97/5/1) 17. ( )(97701K 97702A 97703B) ( ) 89

90 ( ) 1. ( ) 2. (85204C) (1) () (2) 5mm (3) 3. (1) (2) 4. (1) (101/2/1) () (2) (101/2/1) (3) 90

91 (4) (23401C) DBR (A )(23503C) (23001C) (5) (6)( )(86008C) (86009C) (86010B) (7) (86012C) (86012C) (86013C) (8) carbamycholine acetylcholine chloride 1% (9)(101/2/1) () (10) (97/5/1)(99/7/1) (11) (101/2/1) () (12) 91

92 (101/2/1) (13) (99/7/1) (14) ( )(85205C)( ) (15)( ) ( ) ( ) 5.(97/5/1) (1) ( ) (2) (3) ( ) (4) 92

93 (5)(23702C) (PRP) 23702C( ) (6)( FAG Fluorescein Angioraphy) ( ) (7) (86207B)1/2 (85608B) ( ) (85608B) 1/2 (86206B) ( ) (85608B)( ) (86404B) (86403B) 6.(86206B) 93

94 (86207B) (1)86206B (2)86207B 7. (1) (85213B) ( )(85213B)1/2 ( ) (86008C) (2) 8.(1) (101/2/1) (2) (23201C) (23202C) (23203C) (23204C) (23205C) (23206C)(23207C) (23208C) 9.(60001C 60014C) (1) (60003C) (60004C) X2() 60003C 60004C (2)() (60005C)() 94

95 (60006C) 60005C 60006C (3) ( ) (60007C) ( ) ( 60008C ) X C 60008C (101/2/1) (4) ( ) (60011C) ( ) (60012C)YAG 60011C (5)(60013C) (6) (7)(60001C) (60002C)(60003C) (60004C) () (60005C) () (60006C) (8) (9) (Laser Peripheral Iridoplasty)( ) (60011C 60012C)(Laser Membranectomy) (Laser Traction Fibrotic Vitrectomy) (60013C 60014C) (99/7/1)

96 11. (1) ( ) (2) (3) (4) ( ) (5) (6) C (23401C) C (1)(23702C) (23501C) (2) (3) (4) 14.(53024C) ( 9 (97/5/1) D (23001C) 96

97 (97/5/1) 16.(1) 2 (2) (97/5/1) 17. (97/5/1)(99/7/1) 18. (23305C) (97/5/1)(99/7/1) 19. (85201C) 20. (53016C) 21. ( )(99/7/1) 22. (

98 ) 23. ( ) 24. ( ) (99/7/1) C 85205C K-reading (97/5/1) 26.(87004C 87005C 87017C) (99/7/1) 98

99 ( ) 1. (1) (97/5/1)(99/7/1) (2)(51018B 51019B); 2.(51017C)(51021C) (51022C)(95/7/15)(99/7/1) (1)51017C 3 ( ) 2 2cm 2 (shaving) (2)51021C 1 2 1cm (3)51022C cm 2cm 2 (4) 51017C (99/7/1) (101/2/1) 3. 4 (51009C) 4-9 (51010C)9 (51011C) (1) () 99

100 (2) (97/5/1) (1)(51005C) (2)(51006C) 2.(99/7/1) 5.(51020C) (abscess) ( ) (51004C) (1) (2) (3) 8. () 100

101 tranexamic acid 12. Sporanox (itraconazole) Lamisil (terbinafine) azole allylamine (CO2 laser operation)62020b (1)Nevus sebaceous( ) (2)Epidermal nevus() (3) (Periungal warts) 5 ( ) 2 (97/5/1)(99/7/1) (4)Precancerous lesions include actinic keratosis, oral ) (5)Lichen amyloidosis( ) (6)Hemangioma( ) (7)Skin cancers( ) (8)Mibelli (porokeratosis) 101

102 15.Acne therapy 51004C ( ) (1) ( ) (2) 50 (3) (4) PUVA (5) T ( en plaque) PLC PLEVA) (6) (GVHD) PUVA UVA1 (7) 102

103 17. Antihistamine() 2 103

104 () 1. (1) (2) (3) (4) 2. (1) (2) (3) 104

105 ( ) (4) (5) (6) (97/5/1) (7) IV Push (8) 3. (1) (2) CT MRI (3)(37028B 37029B 83081B 83082B 83083B 83084B)() 105

106 (4) (5) 20013B() 20021B( ) (101/2/1) A B (TIA) (6) 20026B() ( TIA) (101/2/1) 4. NCV F-wave H-reflex EEG (1)(20015B 20016B 20019B) (2)H-reflex (20024B) 106

107 spasticity (3)F-waves (20023B) (4)EEG(20001C 20002C 20004B 20005B 20006B) A B C D E F G H I 107

108 A B C D(99/7/1) E A B C D E Alzheimer disease R/O Jakob-Creutzfeldt disease Jakob-Creutzfeldt disease R/O Alzheimer disease (5) 108

109 () 1. (1) maep ILOC (Injury induced Loss Of Consciousness) Skull fracture IICP sign GCS 3 IICP sign (99/7/1) (2) Skull X-ray CXR EKG Blood Routine PT PTT GOT GPT BUN Cr Na K Sugar Brain CT Skull view C-spine pelvis (3) Contaminated deep wound Clean-wound surgical wound 3 Superficial abrasion contusion 109

110 2. coma scale T.P.R coma scale T.P.R 3. CT MRI brain concussion Pulse Oximeter Arterial Blood Gas Perineal care Foley care indication routine 6.Specific gravity ICU care D.I. order 7. 8.Diprivan 1 9. (1)delayed ICH () CT scan recurrent ICH 110

111 complication 1/2 (101/2/1) (2)Spinal stenosis Laminectomy()Discectomy Discectomy 1 Laminectomy 1/2 (3)Open depressed fracture+ich ICH depressed fracture CT Scan (4)Transsphenoidal surgery SMR1/2 Bone Graft 64002B 62009C 10. (1) 3 20 Karnofsky performance scale(kps) 70 ECOG 0-1 (2) (3) 94/2/25 11.NCV/EMG CT/MRI NCV/EMG CT/MRI ( Neuropathic pain 111

112 ) (97/5/1) 12.Disectomy Laminectomy Laminectomy endoscope surgery Laminectomy (97/5/1) 112

113 () (45040C) 45037C 45070C (1) (2)

114 (95/7/15) (1) ( )(45094C) (2) supportive individual psychotherapy 45010C (99/7/1) (3) re-educative individual psychotherapy 45087C 45088C 45089C) (99/6/1) (4) 40 intensive individual psychotherapy 45013C 45090C 45091C 114

115 A. B. (99/7/1) C. D. 40 (5) supportive group psychotherapy 45016C (99/7/1) (6) intensive group psychotherapy 45019C 90 (2) (3) (4) 115

116 (5) (99/7/1) 6. (45019C) 7. (45079C) 8. 9.(45046C 45098C 45099C) (95/7/15) 10.(45055C) 11.(45049C) 12. (45102C) 116

117 13. (95/7/15) 14.( )(97/5/1) (97/5/1) 117

118 () ( ) (100/1/1) 3. ( ) 4. (1) () ( - ) (2) 5. (97/5/1) 6., 7. (101/2/1) () 8.( )( ) 118

119 B 51019B C (101/2/1) C 43023C C B C 42016C ( ) (98/3/1)

120 ( ) ( ) (98/3/1) 18. ( ) (98/3/1) 120

121 () 1. (1) (2) ( ) ( PTCD ) B 36012B B (97/5/1) 10. (19014C)(33005B) 121

122 11. X (37028B) (37029B)(36015B) (36021C) 12.(37026B) B 36018B 122

123 () 1. (25001C) (25002C)(25003C) (25004C)(25024C) (25025C) 25003C 25004C

124 () 1. () (Pulse Oximeter) (57017B) (96025B)(96026B) (97/5/1) C ( ) 8. (IV IM anesthesia)(96004c) C short induction barbiturates( thiopental methohexital) Etomidate Ketamine Propofol ( )( )

125 () C (96/4/1) 125

126 (Tw-DRGs) (99/1/1) ( ) Tw-DRGs ( )Tw-DRGs 1.() (Outlier) ( ) 1.Tw-DRG ICD-9-CM (1) (2) ( ) (3) 126

127 3. (1) (Clinical Evaluation) (Therapeutic Treatment) (Diagnostic Procedures) (Extended Length of Hospital Stay) (Increased Nursing Care and/or Monitoring) (2) 4. (1) (2) (3) 5. Tw-DRG 6. Tw-DRG 127

128 7. Tw-DRG 8. significant procedure ( ) 1. (1) (2) 2.(99/4/1) 3. (99/4/1) (1) 24 (2) (complication) (99/4/1) 128

129 (3) (4) ( ) (5) (99/4/1) (6) (7) ( ) ( )Tw-DRG (100/5/1) ( )Tw-DRG () (100/5/1) 129

130 DRG (100/11/1) MDC2 DRG03904 (BILATERAL LENS PROCEDURES WITHOUT VITRECTOMY) DRG03905 (UNILATERAL LENS PROCEDURES WITHOUT VITRECTOMY) ( ) ( ) 5. ( )() 1. ( )( ) ( ) 2. ( ) DRG

131 MDC5 DRG11201 (MULTIPLE VESSELS AND OTHER PERCUTANEOUS CARDIOVASCULAR PROCEDURES) DRG11202 (SINGLE VESSEL PERCUTANEOUS CARDIOVASCULAR PROCEDURES) DRG11203 (CATHETER ABLATION OF LESION OR TISSUES) DRG11204 (OTHER PERCUTANEOUS CARDIOVASCULAR PROCEDURES) ( ) ( )() 理 ( ) 狀 ( ) 療 療 ( ) 路 律 不 ( ) ( ) 3. ( ) DRG ()( ) (stress testing) ( ) ( ) 201 ( ) 131

132 ( ) ( ) ( ) DRG

133 MDC6 DRG (BILATERAL INGUINAL AND FEMORAL HERNIA PROCEDURESAGE 18 WITH CC) DRG (BILATERAL INGUINAL AND FEMORAL HERNIA PROCEDURESAGE 18 WITHOUT CC) ( ) ( )() ( ) DRG

134 DRG (UNILATERAL INGUINAL AND FEMORAL HERNIAPROCEDURES AGE 18 WITH CC) DRG (UNILATERAL INGUINAL AND FEMORAL HERNIAPROCEDURES AGE 18 WITHOUT CC) ( ) ( )() ( ) DRG ( ) () 134

135 DRG (UNILATERAL HERNIA PROCEDURES AGE 0-17 WITH CC) DRG (UNILATERAL HERNIA PROCEDURES AGE 0-17 WITHOUT CC) ( ) ( )() ( ) DRG ( ) () 135

136 DRG16401 (LAPAROSCOPIC APPENDECTOMY WITH COMPLICATED PRINCIPAL DIAGNOSIS WITH CC) DRG16501 (LAPAROSCOPIC APPENDECTOMY WITH COMPLICATED PRINCIPAL DIAGNOSIS WITHOUT CC) DRG16402 (APPENDECTOMY WITH COMPLICATED PRINCIPAL DIAGNOSIS WITH CC) DRG16502 (APPENDECTOMY WITH COMPLICATED PRINCIPAL DIAGNOSIS WITHOUT CC) DRG16601 (LAPAROSCOPIC APPENDECTOMY WITHOUT COMPLICATED PRINCIPAL DIAGNOSIS WITH CC) DRG16701 (LAPAROSCOPIC APPENDECTOMY WITHOUT COMPLICATED PRINCIPAL DIAGNOSIS WITHOUT CC) DRG16602 (APPENDECTOMY WITHOUT COMPLICATED PRINCIPAL DIAGNOSIS WITH CC) DRG16702 (APPENDECTOMY WITHOUT COMPLICATED PRINCIPAL DIAGNOSIS WITHOUT CC) ( ) 1. fecalith congestion hyperemia phlegmonous 2. acute suppurative appendicitis ( )() ( ) DRG

137 MDC8 DRG20901 (REVISION OF HIP REPLACEMENT WITH CC) DRG20902 (REVISION OF HIP REPLACEMENT WITHOUT CC) ( ) ( )() (CRP ) 6. ( ) DRG

138 DRG20907 (REVISION OF KNEE REPLACEMENT WITH CC) DRG20908 (REVISION OF KNEE REPLACEMENT WITHOUT CC) ( ) ( )() (CRP ) ( ) DRG

139 DRG (HIP AND FEMUR PROCEDURES WITH PDX OR SDX OF INFECTION, EXCEPT MAJOR JOINT,AGE 18 WITH CC) DRG (CLOSE FRACTURE AND OTHER DISEASES AND DISORDERS OF THE MUSCULOSKELETAL S YSTEM AND CONNECTIVE TISSUE HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT,AGE 18 WITH CC) DRG (HIP AND FEMUR PROCEDURES WITH PDX OR SDX OF INFECTION, EXCEPT MAJOR JOINT,AGE 18 WITHOUT CC) DRG (CLOSE FRACTURE AND OTHER DISEASES AND DISORDERS OF THE MUSCULOSKELETAL S YSTEM AND CONNECTIVE TISSUE HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT,AGE 18 WITHOUT CC) DRG21904 (2) 18 (CLOSE FRACTURE AND OTHER DISEASES AND DISORDERS OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT,FEMUR(1) AGE 18 WITHOUT CC) DRG22404 (CLOSE FRACTURE AND OTH ER DISEASES AND DISORDERS OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE SHOULDER, ELBOW OR FOREARM PROCEDURES WITHOUT CC) ( ) 1. ( ) X ( )Open fracture 2.( ) 139

140 ( )() ( ) DRG

141 MDC12 DRG336 (TRANSURETHRAL PROSTATECTOMY WITH CC) DRG337 (TRANSURETHRAL PROSTATECTOMY WITHOUT CC) ( ) DRG ( )IPSS( ) 8 ( )UFR Qmax( ) 15 / ( ) ( ) ( )IPSS 8 ( )UFR Qmax 15 / ( ) 20 ( ) ( ) ( ) ( ) ( ) 2. PSA C ( ) DRG

142 MDC13 DRG35802 (LAPAROSCOPIC HYSTERECTOMY WITHOUT INCONTINENCE WITH CC) DRG35902 (LAPAROSCOPIC HYSTERECTOMY WITHOUT INCONTINENCE WITHOUT CC) DRG35804 (HYSTERECTOMY WITHOUT INCONTINENCE WITH CC) DRG35904 (HYSTERECTOMY WITHOUT INCONTINENCE WITHOUT CC) ( ) ( )() hysterectomy 1.Leiomyomas Leiomyomas (hysterectomy) ( )abnormal uterine bleeding ( )pelvic pain ( )pelvic pressure ( )others ureteral compression uterine growth after menopause rapid growth 2.Dysfunctional Uterine Bleeding ( ) Intractable Dysmenorrhea 142

143 3 3 4.Chronic Pelvic Pain uterine origin (nonsurgical) Cervical Intraepithelial Neoplasia CIN hysterectomy pap smear biopsy conization.recurrent high-grade dysplasia.cin 3 at limits of conization()specimen.poor compliance with follow-up 6.Genital Prolapse symptomatic prolapse feeling of pressure something is protruding from the vagina low backache feeling of heavinessetc. 7.Obstetric Emergency ( )postpartum hemorrhage ( )uterine rupture that can not be repaired ( )placenta accreta increta percreta ( )others 8.Pelvic Inflammatory Disease plevic abscess with uterine involvement 9.Endometriosis conservative surgical treatment( resection or ablation of endometrial implants) 10. ( ) DRG ( )

144 ( ) ( ) ( )() ( ) ( ) 144

145 MDC14 DRG370 (CESAREAN SECTION WITH CC) DRG371 (CESAREAN SECTION WITHOUT CC) ( ) ( )() ( ) DRG ( ) ( ) ( ) ( )() ( ) ( ) 145

146 DRG372 (VAGINAL DELIVERY WITH COMPLICATING DIAGNOSES) DRG37301 (VAGINAL DELIVERY WITHOUT COMPLICATING DIAGNOSES WITH CC) DRG37302 (VAGINAL DELIVERY WITHOUT COMPLICATING DIAGNOSES WITHOUT CC) ( ) ( ) D&C biopsy ( ) DRG Foley

147 (99/7/1) BP SBP<=80 mmhg SBP>=220 mmhg 220>SBP180 mmhg PR RR BT BT>=41 BT<=32 40>BT>39 35>BT>32 >39 renal:colic BSA18-40 surgical airway BSA>40 147

148 148

149 Karnofsky Scale

150 Barthel Score

151 ID

152 12 152

153 PCI Percutaneous Coronary Intervention (97/5/1)(99/7/1) (Chronic coronary artery disease) 1. A.(6 Mets)(99/7/1) B.(stress tests)-201 C. (VT)(VF) (Cardiac arrest) D E. 2. A. a. b c (99/7/1) B. a b. 153

154 c. 154

155 (Acute myocardial infarction, Acute MI) A.(Primary PCI for Acute MI)(99/7/1) a. b. c. (99/7/1) d. B. a. b c. d. e.(infarct-related vessel) A. B (stress testing) a. b. 201 c. d. 155

156 e. C.PCI ab c d PCI (99/7/1) 156

157 EPO 八 十 八 年 元 月 五 日 訂 定 流 水 號 第 一 次 洗 腎 姓 名 出 生 年 月 日 透 析 日 期 透 析 日 期 及 注 射 紀 錄 EPO 總 檢 驗 年 月 日 身 分 證 編 號 年 齡 EPO 劑 量 量 次 數 年 月 日 日 期 日 期 劑 量 2 年 月 日 日 期 日 期 劑 量 3 年 月 日 日 期 日 期 劑 量 4 年 月 日 日 期 日 期 劑 量 5 年 月 日 日 期 日 期 劑 量 6 年 月 日 日 期 日 期 劑 量 7 年 月 日 日 期 日 期 劑 量 8 年 月 日 日 期 日 期 劑 量 9 年 月 日 日 期 日 期 劑 量 10 年 月 日 日 期 日 期 劑 量 1.CAPD EPO CAPD EPO (/) 157 合 計 Hct Hct Hct Hct Hct Hct Hct Hct Hct Hct 總 金 額 NT$ 元 整 BUN 或 Ccr 值 備 註

158

159 1. Ccr 5ml/min Cr 8mg/dl 2. Ccr 15ml/min Cr 6mg/dl () () (BUN>100mg/dl)BUN mg/dl () BUN Cr K Na Hct Co2 159

160 ( ) (18 ) VIATAL SING <3M 3M-3Y >3Y-18Y <3M 3M-3Y >3Y-18Y BP PR RR RR RR RR 40 BT( )

161 ( ) (>38.5 ) 12.> mg/dl () ( ) > mg/dl

162 Hemi-pelvis 162

163 () ID () 1. ( ) 25001C 25002C 25003C 25004C 25024C 25025C 54012C 96004C 96010C 96017C 96020C ( ) 163

164 () ID () ( ) C 25002C 25003C 25004C 25024C 25025C 96004C 96020C ( ) 164

165 PTS2 PTS3 PTS4 PTS6 PTS7 PTS8 PTS9 PTS10 PTS12 PTM2 PTM3 PTM4 165

166 () 166

167 PTS PTS PTS PTS PTS PTS PTS PTS PTS PTS PTS PTS PTS PTS PTM PTM PTM PTM PTM PTM PTM PTM PTM PTM PTM PTM

168 PTM PTC PTC PTC PTC PTC PTC C PTC1-PTC6 168

169 ( ) cerebrovascular accidents (CVA) ( ) cervical syndrome ( ) low back syndrome ( ) spinal cord injury ( ) amputation 1.BK BE 2.AK AE ( )frozen shoulder ( ) facial palsy ( ) arthritis ( ) fractures ( ) other orthopaedic disease () sprain & strain () cerebral palsy () head injury () poliomylits ()Peripheral nerves injury 1.(peroneal ulnar median radial) 2. () other neurological disease () total hip & knee () chest rehabilitation 1. pre & post chest operation 2. COPD () others

170 1 2 (ROM_G) 3 (MUSCLE_G) 4 (SEN_G) 5 (MOTOR_G) 1A 1B 2A 2B ( 1.(0-20 ) 2. (21-40 ) 3.(41-70 ) 4. 2C (71-90 )) 3A 3B 3C 3D 3E 3F 4A 4B 5A 6 (AERO_G) 6A 6B 170

171 7 (Device) 1 2 7A (SPEC_G) 1A 2A () 2C(joint play) 3A 3C 3E 4A 5A 6A 6C 6E 1B 2B 3B 3D 3F 4B 6B 6D 6F 7A (P89 P155) 171

172 172 (Muscle flexibility) / / (Joint mobilization technique) / / // ( )

173 1.E.K.G. 1. ( 2.X-ray ) 2. () ( ) ( ) () ( ) () ( ) () ( ) (ASA) 4.( ) C C 7.( 96007C ) 96011C ( i.v.regional) C C C

174 ASA PRE-OP DX ANES METHOD SEX HT DATE OR( ) <<<<>>>> AGE WT. PREVIOUS ANES HX Y/N NPO Y/N ANESTHESIOLOGIST RESIDENT PRE-OP CONDITION A.B O AB RH +/- SURGEON ANESTHETIC NURSE AGENTS PROCEDURE INTUBATION S. # C.X.A.B.F. L. cm N.O.D.T. PREMEDICATION FLUID N2O O2 INDUCTION EBL URINE SpO2 ETCO2 TIME BP HR BT ANESX MONITOR ECG NIBP SpO2 ETCO2 TEMP TOTAL INTAKE A-LINE CVP PA Cath EEG TEE CRYSTALLOID cc TV/RR COLLOID cc PEAK AWY WHOLE BLOOD u CVP PACK RBC u PLATELET u PH FFP u PO2 PCO2 BE Na/K Ca TOTAL OUTPUT Hct SUGAR COMMAND BLOOD LOSS cc URINE cc NG cc OTHER 32 IN-/ 150 Exiube 30 ^/v OP 100 BP / mmhg HR 50 SPONT ASSIT /min CONTL REMARK POSITION 174

175 ICD-9-CM () Acute Bronchitis Bronchopneumonia, Organism Unspecified Acute Upper Respiratory Infection 10000(Seg>80 or Ban>5 ) 20,000 6, ,000/mm 70,000/mm 493 Astahma Torr 40 Torr Chronic Bronchitis Renal Satone Ureter Stone (include stone street after ESWL) (PaO2<60)>30 /min a. 0.5cm b. 0.5cm 175

176 ICD-9-CM () Gastric Ulcer 532 Duodenal Ulcer Peptic Ulcer Gastritis and Duodenitis a. b. c Liver Cirrhosis Hepatitis SGPT>300 Bilirubin > Vertiginous syndromes and other Disease of Vestibular system Nephritis and Nephropathy U.T.I Cystitis Urethritis Essential Hypertension Hypertensive Heart Disease Concussion Intracranial Injury Other Open Wound of Head (Hypertensive crisis) 2 Glasgow Coma Scale

177 ICD-9-CM () Contusion of Trunk 891 Open Wound of knee, Leg (except Thigh) and Ankle 10 5 Rhabd omyolysis 10 2 Avulsion FlapTendon Rupture Hemoarthrosis

178 (100/11/1)() * ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) 178

179 ( ) 1 8 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) () 179

180 () () () () () () ( ) cephalothin, cefazolin, cephradine, cephaloridine, cephapirin ( ) cephamycin cefamandole, cefonicid, cefuroxime,cefotiam ( ) Cephamycin cefoxitin, cefmetazole ( ) Pseudomonas cefotaxime, ceftizoxime, ceftriazone, cefmenoxime ( ) Aminoglycoside tobramycin netilmicin 180

181 ( ) Fluoroquinolone norfloxacin, ofloxacin, enoxacin, ciprofloxacin ( ) Glycopeptide vancomycin teicoplanin ( ) β-lactamase inhibitor Augmentin Unasyn ( ) ( ) (99/7/1) ( ) () (97/5/1) 1., 2. (1)( ) ( ) (2) 181

182 (3) (4), (95/7/15) 182

183 (98/3/1) (95/12/1) (99/1/1) (99/4/1) Screen 23610C 54018C 08030C 4 mmhg, mg/dl 3. 6mg/dl 4. 6mg/dl 10 mg/dl

184 -HCG 1. () C ( ) C

185 (100/5/1) 22001C C 27001C 09112C 97017C ( ) B 3. ( 4. B 1. T3 toxicosis 2. T3 toxicosis HCG 185

186 ( ) /6/1 (1) 10.2 Penicillins & 10.3 Cephalosporins (100/1/1) (2) (100/1/1) (3) (100/1/1) (1)( ) (2) (3) 186

187 (4) (5) (6) (7) (8) 48004C 48006C 48022C 48024C 48033C 48035C (97/5/1) (9) (10) (11) Balance Salt Solution Physiologic Irrigating Solution (12)64141C (13) 187

188 (14) (15)(97/5/1) (16) ( ) (97/5/1) ( ) 1. IV Push 57111C B 4. (100/1/1)

189 8. (97/5/1) tocolytics β-mimetics (1)(vial) (2)(ampoule) 14. (54019C 54027C 54037C 54038C) (97/5/1) ( ) () 189

190 1. 2. ( ) IV Push ( ) % blood gas ( ) 190

191 ( )1. (1) (100/1/1) (2) X (100/1/1) (3) (100/1/1) ( ) 1. (1) (2) ( ) 2. (1) KARNOFSKY SCALE() ( ) BARTHEL S SCORE()60 ( ) A 191

192 B C (2) (3) 3. (1) ( ) ( ) (2) ( ) 192

193 ( ) (99/7/1) ( ) 1. IgE 20 (100/1/1) 2. ()(30021C) 30022C ( )( ID ) ()() (97/5/1) () COXⅡ NSAID antacid () (IDF) 2002 WHO 193

194 () ()1.( ) 2. TG( ) fibrate () Sono 30% 194

195 ( ) MRI CT ( ) ( ) 9. (100/1/1) 10. sulfonylureas glimepiride meglitinides 195

196 repaglinide nateglinide(97/5/1) 11.TZD thiazolidinedione (97/5/1) (1)(IGT) (2) (3) (4) 3 6 HbA1c metformin metformin TZD 12. GPT:46 B C (97/5/1) (1)B B (2) B C (3) (4 B C C 19009C (99/4/1)(100/1/1) 13. (97/5/1) (1) 6 1 (2) (3) urine 1 196

197 14.(99/4/1) (1) (2) 15.(100/1/1) ( ) IV Push B GOT GPT HBSAG Anti HCV Anti HBS 8. CCr 10 ml/min UF<2.0 CCr (97/5/1) 197

198 Ccr 24 Cr measured Ccrestimated Ccr CG-GFR Cockcroft-Gault = 140-Age Bwt / 72 Cr 1.73/ BSA 0.85 if female MDRD-Simplify-GFR=186 Scr Age if female 1 Cr 6.0 CCr 5ml/min Ccr 24 CG MDRD UF< (2) BMI data residual renal function CCR Albumin 9.BC 1 ALT ( bilirubin >2mg/dL, PT prolong>3 sec) BC HBV DNA HCV RNA 2 B 6 12 HBV DNA 198

199 3 C ( RVR) 6 HCV RNA 4 6 (99/7/1) ( ) () ( ) IV Push B 199

200 B ( ) % blood gas ( ) 1.EPO ( ) 2. (1) Kt/V (2) Kt/V /1.73 (100/5/1) 200

201 3. (97/5/1) (1)18005B() 18006B( ) 18007B( ) (2)18007B 18006B (3)18007B 6. 2 (single lumen) 47015B( ) (double lumen) 69006C( ) 7. UGI series 8. CPR 201

202 (97/5/1) 11. EPO ( ) C(CAVH) (1) (2) (3) severe volume overloading (96/4/1) (96/4/1) C (96/4/1) B C C (96/4/1)

203 (97/5/1) 16. Port-A 48010C 17. (WBC 1,500 50,000) 08011C 18. (96/4/1) (1) 1 (2) 1 ( ) (3) 19. (96/4/1) (1) (2) (/ (69006C) (47059B 47061B)): CCr 15 ml/min (Cr) 6.0 mg/dl A., B., C., D. 203

204 , E., F., G., H. (cachexia), I. (BUN > 100 mg/dl) A C B.69034C C B 47061B A. (A) CCr 15 ml/min (B) (Cr) 6 mg/dl (C) B. (AV graft) (A) CCr 12.5 ml/min (B) (Cr) 7 mg/dl (C) C. 204

205 (AV graft) (A) CCr 10 ml/min (B) (Cr) 8 mg/dl (C) D. 30 (Cr) 6 mg/dl 4 (Cr) 5 mg/dl (3) B A. CCr 15 ml/min B. (Cr) 6 mg/dl C. A. CCr 10 ml/min B. (Cr) 8 mg/dl C. 30 (Cr) 6 mg/dl 4 (Cr) 5 mg/dl ( ) (IDF) 2002 WHO ( )1. IgE

206 (100/1/1) 2. ()(30021C) 30022C ( )1. (99/4/1) 2. TG( ) fibrate ( ) Sono 30% ( )1.fatty liver GPT 1-2, fatty liver 2.Sono () () ()1. 2. IGE(12031C) 08010C (Eosinophil count)()(30021c) (30022C) 206

207 ( ) ( ) (99/4/1) 3.(97/5/1) (1)() (2) C C 6 (99/4/1) (3) %TBSA(Total body surface area) 48014C 48018C C (99/4/1) 207

208 6. ( ) ( ) ( ) ( ) balance salt solution physiologic irrigating solution ( )( ) ( ) (Split thickness skin graft) ( ) ( ) 1. ( ) (1) B 69015B (2) B (3)(1) (2) B B 1/

209 2. ( ) 69014B 69015B 3.( ) ( ) 69016B 69017B ( ) 69032B() () () 48024C ( ) () C () (62009C) 10CM 75602C() C( ) ()(clean wound) (open drainage) (infected wound) () () 209

210 () ()(49004C) 49004C 48013C () 83048C () 1. 2.Danzen Varidase () ( ) ( )(51020C) ( )(64116B) (62010C) (62010C) (64116B) ( ) (48001C) (56006C) ( ) ( )(18008B) 210

211 1.(PAOD) 2. (IABP) 3.(ECMO) 4. ( )RH(D) (11003C) 1. Rh0(D) 2. ( )(29017C) (95/12/1) (29017C) 211

212 ( ) (78607C 4550 ) ( ) tendon repair ( )(64208C) ( )1.clean wound 2 2. unclean wound ( ) 48027P 48028P ( ) (97/5/1) ( )(97/5/1) ( )Danzen Varidase (97/5/1) 212

213 ( ) (97/5/1) ( ) 48033C 48034C 48035C (97/5/1) ( )(74417C) : (97/5/1) ( ) (97/5/1) 213

214 ( ) (99/4/1) Penicillins & 10.3 Cephalosporins (97/5/1)(100/1/1) 4. 5.( ) 6. 7.(97/6/1) (1) (2) (3) (100/1/1) (4) 1 214

215 2 3 ( ) (100/1/1) 8. (99/4/1) C( ) 10.() (100/1/1) 12. Nebulizer (99/4/1) 13. O2 tent O2 hood (57014B) (100/1/1) 215

216 ACEI ARB Aldosterone X X X X X X X X X ( ) 1. 2.( ) ( ) ( ) 1. ( )

217 3. (1) (2) (3) 4. (57009B) (1)AMBU bag 57009B (2)IMV Resuitator( ) IMV 57009B( ) 5.Postural drainage(47045c) Postural drainage(47045c) special sheet ( ) COX NSAID ( )1. COXⅡ NSAID antacid antacid 2. NSAID antacid ( )1. IgE 20 (100/1/1) 2. ()(30021C) 30022C

218 ( )( ID ) ( )1. 2. TG( ) fibrate ( ) Sono 30% ()1.fatty liver GPT 1-2, fatty liver 2.Sono ()1. 2. specific allergen test IgE(12031C) 08010C (Eosinophil count)()(30021c) (30022C) (99/4/1)(100/1/1) ()2 Menthol Packing (97/5/1) 218

219 ( ) C ( ) C

220 7. ( ) (99/4/1) 3. (97/5/1) (tocolytics) ()( ) 7.Clomiphene citrate (101/2/1) ( ) 80403B80412B 80413B B 220

221 B (parametrium) B 80414B 70208B 70209B ( ) 4. (80402B) stage biopsy 81014B ( ) 80014C ( ) 1. (1) (2) (3) (4) (5)

222 ( ) ( ) ( ) ( ) ( ) C C () (80403B) (80404B) 3. () 222

223 1.Fetal distress( ) 2.Failure to progress in active labor() 3.APH(placenta previa, abruptio placenta)() 4.Malpresentation (including twin with malpresentation)( ) 5.Cord prolapse() 6.Induction failure( ) 7.Active genital herpes() 8.Previous C/S( ) 9.Previous uterine surgery() 10.Vulvar and/or vaginal condyloma acuminata, diffuse( ) 11.Treatable fetal anomalies(e.g. gastroschisis, omphalocele, hydrocephaly)( ) 12.Preeclampsia with() (1)uncorrectable severe preeclampsia (2)HELLP syndrome with failed induction (6hrs) (3)eclampsia with poor induction progress (6hrs) 13.Extremly premature fetus < 1500gm( NICU ) ( <1500 ) 14.Pelvic deformity (sequela of poliomyelitis or traffic 223

224 accident, etc.)() 15.Fetal macrosomia (>4000gm EBW)(>4000 ) 16.Cephalopelvic disproportion (CPD)( ) 17.Obsructive labor (e.g. myoma, ovarian tumor) ( ) 18.Major medical complications( ) 19. HIV(+)(98/8/1) 20. (98/8/1) () MTX () (101/2/1) () () (101/2/1) () () (28014C) () (18013C 18014C) 18035B 224

225 () () () urine acetone ( )Folliculometry ( ) ( ) IUD IUD displacement ( ) PAP smear () ( )C/S (ATH,VTH ) 1.C/S (ATH,VTH ) 2.(ATH,VTH ) ( ) (99/4/1) ( ) (97/5/1)

226 3. ( ) 1. (D&C) 2. (D&C) 3. ( ) ( ) ( ) ( ) Pulse or ear Oximetry (57017B) (47031C) ( ) 1. (1)17 (2)17 29 (3) (99/4/1) ( )1.(97/5/1) 2. (100/1/1) 226

227 ( )( NST ) (97/5/1) ( ) 55015C(97/5/1) 227

228 ( ) (64245C 64246B 64247C) kpin ( ) ( )()( ) ( ) 1. multiple fracture (2 components )2. open fracture 3. pediatric fracture 4. complications neuro vascular injury visceral organ injury infections etc 5. joint fracture or joint dislocation (101/2/1) 6. special condition femoral neck fracture ( ) CRP ESR (97/5/1) ( ) ( ) (100/1/1) ( ) X 228

229 X X X X (95/12/1) (100/1/1) ( ) X () () X (95/12/1)(100/1/1) ( ) X X (95/12/1) ( (100/1/1) 229

230 ( )(79404B 79405B 79406B 79411B 79412B 97401K 97402A 97403B) 1. (97/5/1) 2. BPH C C (97/5/1) ( ) (79407C) ( ) 1. ( ) U.V.J.stone ( )(78026C)

231 3. (ESWL) (1) A.KUB Sono B.IVU 3.RP (2)ESWL ESWL (3) () (4) ( ) Eviprostate Nephronorm (101/2/1) ( ) PGE1 60mcg ( )(99/4/1) ( ) Video-urodynamic study (21006B) (21004C)(21007C)(21003C) 231

232 ( ) (50010C) ( ) (05221A) (50011C) (37005B) 05221A ( )50020C (97/5/1) 1. (paraphimosis) ()BPH bethanechol (97/5/1) 1.BPH bethanechol finasteride -blocker 3 2. on Foley detrusor 3. DM 1 4.DM AUR 232

233 5.NB neurogenic bladder urinary retention on Foley 233

234 ( ) ( ) 54023C ( )(57007C) (57021C) ( ) ( ) (101/2/1) ( ) ( ) - (54019C)- (54027C) (54037C) (54038C) (99/4/1) (100/1/1) ( ) SMT UPPV 234

235 (101/2/1) () ( ) (97/5/1) B 65074C 1 Wound treatment and change dressing 54027C 5 5 (99/4/1) C 3.()(65003C) ( ) ( )1.(VFT) Nann Romberg VFT ()1. 2. IGE(12031C) 08010C 235

236 (Eosinophil count)()(30021c) (30022C) ()1. IgE 20 (100/1/1) 2. ()(30021C) 30022C () 14 (97/5/1)(100/1/1) () ( ) (97/5/1) 236

237 ( ) ( ) ( ) 1. ( ) 2. 5mm ( ) (99/7/1) 6.(100/1/1) ( ) ( ) 1. (101/2/1) ()

238 (101/2/1) 3. 4.(23401C) DBR (A )(23503C)(23001C) C 86009C 86010A C 86012C 86013C 8. carbamycholine acetylcholine chloride 1% 9.(101/2/1) () 10. (97/5/1)(100/1/1) 11.(101/2/1) () 12. (101/2/1)

239 C K-reading 53010C (97/5/1) C 86007C 86008C 86011C 86012C 86013C ( ) 1.() ( ) 4. 5.(23702C) 239

240 (PRP) 23702C( ) 6.( FAG Fluorescein Angioraphy) 7. (1) 86207B 1 / B ( ) (2) 85608B 1 / B ( ) (3)85608B( ) (4) 86404B (5) 86403B ( )86206B 86207B B B ( ) 1. (85213B) ( 240

241 )(85213B) 1 /2 ( )(86008C) 2. ( )1. (101/2/1) 2. (23201C) (23202C) (23203C)(23204C) (23205C) (23206C)(23207C) (23208C) ( )(60001C 60014C) C 60004C X2() 60003C 60004C C 60006C 60005C 60006C C 60008C X C 60008C (101/2/1) C 60012C YAG 60011C C 241

242 6. 7.(60001C) (60002C)(60003C) (60004C) () (60005C) () (60006C) 8. ( ) () 1. ( ) ()23706C (23401C) () 23803C 1.(23702C) (23501C)

243 3. 4. () 53024C 9 (97/5/1) () 2.0D 23001C (97/5/1) () (97/5/1) () (97/5/1)(99/7/1) ()23305C (97/5/1)(99/7/1) () (85201C) () 53016C 243

244 ( ) (99/7/1) ( ) ( ) ( ) (99/7/1) 53010C 85205C K-reading (97/5/1) 87004C 87005C 87017C (100/1/1) 244

245 ( )(51017C) 51021C 51022C (95/12/1) 1.(99/7/1) (1)51017C 3 ( ) 2 2cm 2 (shaving) (2)51021C 1 2 1cm (3)51022C cm 2cm 2 (4) 51017C (99/7/1) (101/2/1) ( ) 51009C 51011C ( ) 1. (1)51005C 245

246 (2)51006C 2. ( ) 51020C (abscess) 51004C ( ) ( ) () ( ) ( ) tranexamic acid ( ) Sporanox (itraconazole) Lamisil(tenbinafine) azole allylamine (97/5/1)(100/1/1) ( ) ()Acne therapy 51004C ( ) ()Tazorac Silkis (101/2/1) () ()Elidel Protopic Oint 246

247 () 2 () (101/2/1) () () 62001C 62010C 51003C () (95/12/1) (101/2/1) ()(30022C) IGE(12031C) (08010C ) (30022C) (95/12/1) () (95/12/1) () Antihistamine() 2 (97/5/1) acyclovir (99/7/1) 247

248 ( ) ( ) CT MRI 3.()

249 B() 20021B( ) (101/2/1) (1) (TIA) (2) (3) B() ( TIA) (101/2/1) ( ) NCV, F-wave, H-reflex EEG 1. (1) (2) (3) (4) (5) 2.H-reflex (1) (2) (3) spasticity 249

250 3.F-waves (1) (2) (3) (4) 4.EEG EEG (1) (2) 250

251 (99/7/1) (3) Alzheimer disease R/O Jakob-Creutzfeldt disease Jakob-Creutzfeldt disease R/O Alzheimer disease 5. ( ) blood gas 251

252 252

253 ( ) coma scale T.P.R ( ) CT MRI brain concussion ( ) Pulse Oximeter ( )() (57017B 57018B) Arterial Blood Gas ( )Perineal care Foley care indication routine ( ) Specific gravity ICU care D.I. order ( ) ( )Diprivan ( ) 1.Delayed ICH () CT scan recurrentich complication 2.Spinal stenosis Laminectomy()() (83003C)() Diskectomy(83022C) (83023C)(83024C) Diskectomy 253

254 1 Laminectomy(83002C 83003C) 1/2 3.Open depressed fracture+ich ICH depressed fracture CT Scan 4.Transsphenoidal surgery SMR 1/2(65004C) Bone Graft 64002B 62009C 254

255 ( ) ( ) (45040C 45041B 45042C) ( ) ( ) (1) (2) ( ) 255

256 (3) (4) ( ) (95/7/15) 1.( )(45094C) 1 (100/1/1) supportive individual psychotherapy 45010C (99/6/1) 3. re-educative individual psychotherapy 45087C 45088C 45089C 1 2(99/7/1) 3 (99/7/1) 256

257 4. 40 intensive individual psychotherapy 45013C 45090C 45091C A. B. (99/7/1) C. D supportive group psychotherapy 45016C (99/7/1) 6. intensive group psychotherapy 45019C

258 (99/7/1) ( )1. 2. (45037A 45038B 45039C) ( ) (45034A,45035B,45036C) ( ) (45079C 45080B 45081C) 258

259 ( ) ( )(45046C 45098C 45099C) (95/7/15) ()(45055C 45056B 45057C) () (95/7/15) 259

260 ( ) ( ) (97/5/1) 1. () 2. ( ) ( )(100/1/1) ( )( ) ( ) ( ) 41005C ( ) 41006B 260

261 ( ) 51018B 51019B ( ) 47039C -- ( )43010C 43023C ( ) ( ) () (97/5/1) () (myofascialpain) 1. ( ) 39018C() 2.. (Trigger Point Inj).( ). (), () 261

262 () (101/2/1) () () ( ) ( ) () 42016C 42016C ()(101/2/1) () X (95/12/1) ()X X (95/12/1) ( ) X X (95/12/1) ( ) 262

263 ( ) (97/5/1) ( ) (97/5/1)(99/7/1) X- (100/1/1) 263

264 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( PTCD ) ( ) ( ) 36011B 36012B 264

265 ( )(25001C 25003C) ( SNOMED coding number) ( SNOMED coding number ) ( SNOMEND coding number ) ( ) ( ) ( ) 25001C 265

266 ( ) () (Pulse Oximeter)(57017B) ( ) ( ) ( ) ( ) ( ) (96025B)(96026B) ( )96003C ( ) (IV IM anesthesia)(96004c) ( )96004C short induction barbiturates thiopental methohexital Etomidate Ketamine Propofol 266

267 ( ) () () 96011C 267

268 BP SBP<=80mmHg SBP>=220mmHg 220>SBP180mmHg PR RR BT BT>=41 BT<=32 40>BT>39 35>BT>32 >39 renal:colic BSA18-40 surgical airway BSA>40 268

269 Karnofsky Scale

270 Barthel s Score

271 ID

272 12 272

273 EPO EPO EPO CAPD EPO CAPD EPO (/) Hct Hct Hct Hct Hct Hct Hct Hct Hct Hct NT$ BUN Ccr 273

274 1. Ccr 5ml/min Cr 8mg/dl 2. Ccr 15ml/min Cr 6mg/dl () () (BUN>100mg/dl)BUN mg/dl () BUN Cr K Na Hct Co2 274

275 ( ) (18 ) VIATALSING <3M 3M-3Y >3Y-18Y <3M 3M-3Y >3Y-18Y BP PR RR RR RR RR 40 BT( ) ( ) (>38.5 ) 12.> mg/dl () ( ) > mg/dl

276 Hemi-pelvis 276

277 () ID () ( ) C 25002C 25003C 54012C 96004C 96010C 96017C 96020C ( ) 277

278 () ID () ( ) C 25002C 25003C 25004C 96004C 96020C ( ) 278

279 PTS2 PTS3 PTS4 PTS6 PTS7 PTS8 PTS9 PTS10 PTS12 PTM2 PTM3 PTM4 279

280 () 280

281 PTS PTS PTS PTS PTS PTS PTS PTS PTS PTS PTS PTS PTS PTS PTM PTM PTM PTM PTM PTM PTM PTM PTM PTM PTM PTM

282 PTM PTC PTC PTC PTC PTC PTC C PTC1-PTC6 282

283 ( ) cerebrovascular accidents (CVA) ( ) cervical syndrome ( ) low back syndrome ( ) spinal cord injury ( ) amputation 1.BK BE 2.AK AE ( )frozen shoulder ( ) facial palsy ( ) arthritis ( ) fractures ( ) other orthopaedic disease () sprain & strain () cerebral palsy () head injury () poliomylits ()Peripheral nerves injury 1.(peroneal ulnar median radial) 2. () other neurological disease () total hip & knee () chest rehabilitation 1. pre & post chest operation 2. COPD () others

284 1 1A 1B 2 (ROM_G) ( 1.(0-20 ) 2. (21-40 ) 3.(41-70 ) 4. (71-90 )) 2A 2B 2C 3 (MUSCLE_G) 3A 3B 3C 3D 3E 3F 4 (SEN_G) 4A 4B 5 (MOTOR_G) 5A 284

285 6 (AERO_G) 6A 6B 7 (Device) 1 2 7A (SPEC_G) 1A 2A () 1B 2B 2C(joint play) 3A 3C 3E 4A 3B 3D 3F 4B 5A 6A 6B 285

286 6C 6E 6D 6F 7A (P89 P155) 286

287 287 (Muscle flexibility) / / (Joint mobilization technique) / / // ( )

288 1.E.K.G. 1. ( 2.X-ray ) 2. () ( ) ( ) () ( ) () ( ) () ( ) (ASA) 4.( ) C C 7.( 96007C ) 96011C ( i.v.regional) C C C

289 ASA PRE-OP DX ANES METHOD SEX HT DATE OR( ) <<<<>>>> AGE WT. PREVIOUS ANES HX Y/N NPO Y/N ANESTHESIOLOGIST RESIDENT PRE-OP CONDITION A.B O AB RH +/- SURGEON ANESTHETIC NURSE AGENTS PROCEDURE INTUBATION S. # C.X.A.B.F. L. cm N.O.D.T. PREMEDICATION FLUID N2O O2 INDUCTION EBL URINE SpO2 ETCO2 TIME BP 40 HR 38 BT ANESX 34 MONITOR ECG NIBP SpO2 ETCO2 TEMP TOTAL INTAKE A-LINE CVP PA Cath EEG TEE CRYSTALLOID COLLOID WHOLE BLOOD u CVP PACK RBC u PLATELET u PH FFP u PO2 PCO2 BE Na/K Ca TOTAL OUTPUT Hct SUGAR COMMAND BLOOD LOSS cc URINE cc NG cc OTHER 32 IN-/ 150 Exiube 30 ^/v OP 100 BP / mmhg HR 50 SPONT ASSIT /min CONTL REMARK POSITION cc TV/RR cc PEAK AWY 289

290 ICD-9-CM () Acute Bronchitis Bronchopneumonia, Organism Unspecified Acute Upper Respiratory Infection 10000(Seg>80 or Ban>5 ) 20,000 6, ,000/mm 70,000/mm 493 Astahma Torr 40 Torr Chronic Bronchitis Renal Satone Ureter Stone (include stone street after ESWL) (PaO2<60)>30 /min a. 0.5cm b. 0.5cm 290

291 ICD-9-CM () Gastric Ulcer Duodenal Ulcer Peptic Ulcer Gastritis and Duodenitis a. b. c Liver Cirrhosis Hepatitis Vertiginous syndromes and other Disease of Vestibular system Nephritis and Nephropathy U.T.I Cystitis Urethritis Essential Hypertension Hypertensive Heart Disease Concussion Intracranial Injury Other Open Wound of Head SGPT>300 Bilirubin >3 (Hypertensive crisis) 2 Glasgow Coma Scale

292 ICD-9-CM ( ) Contusion of Trunk 10 5 Rhabd omyolysis Open Wound of knee, Leg (except Thigh) and 2 Ankle Avulsion Flap Tendon Rupture Hemoarthrosis

293 (97/5/1) A. GOT GPT B. GOT GPT 2 HBV or HCV C. GOT GPT 2 HBV or HCV D. E

294 (IDF) 2002 WHO Type 2 Diabetes Practical Targets and Treatments The Overweight or Obese Person With Diabetes TABLE 2 Management algorithm for overweight and obese type 2 diabetes mellitus. Failure Add biguanide, TZD or -glucosidase inhibitor Failure Combine two of these or add sulphonylurea Or glinide Failure Add insulin OR change to insulin Check Adherence at Each step TZD=thiazolidinedione If control is poor, oral agents may be started early In certain a situations, insulin may be required (see text for details) 294